Olema Pharmaceuticals, Inc. (OLMA)
USD 5.85
(-4.72%)
USD 5.85
(-4.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 377 Thousand | 1.65 Million | 1.66 Million | 11 Thousand | 9033.00 | 8244.00 |
| Gross Profit | -377 Thousand | -1.65 Million | -1.66 Million | -11 Thousand | -9033.00 | -8244.00 |
| Operating Expenses | 104.96 Million | 106.98 Million | 71.49 Million | 21.52 Million | 4.32 Million | 2.07 Million |
| Selling, General and Administrative Expenses | 18.82 Million | 24.71 Million | 20.39 Million | 7.82 Million | 403 Thousand | 386 Thousand |
| Research and Development Expenses | 86.14 Million | 82.27 Million | 51.1 Million | 13.7 Million | 3.92 Million | 1.69 Million |
| Other Expenses | - | -27 Thousand | -47 Thousand | - | - | -31 Thousand |
| Cost and Expenses | 104.96 Million | 106.98 Million | 71.49 Million | 21.52 Million | 4.32 Million | 2.07 Million |
| Operating Income | -104.96 Million | -106.98 Million | -71.49 Million | -21.52 Million | -4.32 Million | -2.07 Million |
| Interest Expense | - | - | - | 653 Thousand | - | 28 Thousand |
| Income Tax Expense | - | -2.2 Million | -210 Thousand | 642 Thousand | -155.86 Thousand | -90 Thousand |
| Earnings before Tax | -96.65 Million | -104.78 Million | -71.09 Million | -22.12 Million | -4.31 Million | -2.19 Million |
| Net Income | -96.65 Million | -102.58 Million | -70.88 Million | -22.76 Million | -4.31 Million | -2.19 Million |
| Earnings Per Share Basic | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
| Earnings Per Share Diluted | -2.14 | -2.56 | -1.79 | -0.58 | -0.11 | -0.16 |
| Weighted Average Shares Outstanding | 45.24 Million | 39.99 Million | 39.52 Million | 39.3 Million | 40.16 Million | 14.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.24 Million | 39.99 Million | 39.52 Million | 39.3 Million | 40.16 Million | 14.09 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -104.58 Million | -103.12 Million | -69.43 Million | -21.51 Million | -4.3 Million | -2.16 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 1.88 Million | - | - |
| Cost of Revenue | 94 Thousand | 88 Thousand | 377 Thousand | 88 Thousand | 90 Thousand | 425 Thousand |
| Gross Profit | -94 Thousand | -88 Thousand | -377 Thousand | 1.79 Million | -90 Thousand | -425 Thousand |
| Operating Expenses | 33.43 Million | 34.33 Million | 104.58 Million | 30.32 Million | 23.34 Million | 21.6 Million |
| Selling, General and Administrative Expenses | 4.32 Million | 4.45 Million | - | 4.45 Million | 3.88 Million | 3.61 Million |
| Research and Development Expenses | 29.1 Million | 29.88 Million | - | 25.87 Million | 19.45 Million | 17.98 Million |
| Other Expenses | 40 Thousand | 17 Thousand | - | 93 Thousand | -79 Thousand | -44 Thousand |
| Cost and Expenses | 33.53 Million | 34.33 Million | 104.96 Million | 30.41 Million | 23.34 Million | 21.6 Million |
| Operating Income | -33.53 Million | -34.33 Million | -104.96 Million | -30.41 Million | -23.34 Million | -21.6 Million |
| Interest Expense | - | - | - | 1.31 Million | - | - |
| Income Tax Expense | - | -3.35 Million | - | 4.78 Million | -1.91 Million | -1.55 Million |
| Earnings before Tax | -30.38 Million | -30.97 Million | -96.65 Million | -26.77 Million | -21.5 Million | -20.09 Million |
| Net Income | -30.38 Million | -30.97 Million | -96.65 Million | -26.77 Million | -21.5 Million | -20.09 Million |
| Earnings Per Share Basic | -0.54 | -0.56 | - | -0.49 | -0.48 | -0.49 |
| Earnings Per Share Diluted | -0.54 | -0.56 | - | -0.49 | -0.48 | -0.49 |
| Weighted Average Shares Outstanding | 56.28 Million | 55.57 Million | 45.24 Million | 54.78 Million | 44.97 Million | 40.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 56.28 Million | 55.57 Million | 45.24 Million | 54.78 Million | 44.97 Million | 40.72 Million |
| Gross Margin | - | - | - | 0.95 | - | - |
| EBIT Margin | - | - | - | -16.10 | - | - |
| Profit Margin | - | - | - | -14.21 | - | - |
| EBITDA | -33.43 Million | -34.25 Million | - | -30.32 Million | -23.25 Million | -21.5 Million |
| Earnings Before Tax Margin | - | - | - | -16.14 | - | - |
GCTK
VIPCLOTHNG
ZUARIIND
SCHAEFFLER
PRIVISCL
IIQ